Published in J Thorac Imaging on July 01, 2016
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov (2011) 4.60
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J Infect Dis (2012) 1.44
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn (2003) 1.20
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol (2015) 0.97
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg (2012) 0.90
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. Clin Chim Acta (2013) 0.87
The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer (2011) 0.83
Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers. J Thorac Oncol (2014) 0.78
Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial. BMC Cancer (2007) 0.78
Caring for the dying patient with lung cancer. Chest (2002) 0.78
The role of radiotherapy and chemotherapy for curative management of medically inoperable and stage III nonsmall cell lung cancer, and radiotherapy for palliation of symptomatic disease. Respir Care Clin N Am (2003) 0.75
How to insource. A blueprint for bringing food service back in-house. Mod Healthc (2009) 0.75